Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Sol-Gel Anti-Acne Clinical Study Shows Significantly Improved Efficacy And Safety
Sol-Gel Technologies Ltd, a specialty pharmaceuticals company, announced today results from a comparative clinical study. The results demonstrate that the company"s two strength Anti-Acne kits achieved pronounced efficacy and markedly improved tolerability. The study will be presented at the 10th International Congress of Dermatology in Prague, May 20-23, 2009.

Ilaris® Recommended For European Approval As New Biologic Drug To Treat A Rare But Serious Group Of Auto-inflammatory Diseases
The biotechnology medicine Ilaris® (canakinumab) has passed another major milestone with a recommendation for approval in the European Union to treat patients with a life-long and potentially fatal auto-inflammatory disease called cryopyrin-associated periodic syndrome (CAPS). When approved, Ilaris will be the only treatment in the EU indicated for CAPS patients aged four years and older[1].
News of the day
Democrats Are Increasingly Confident About Reform
Despite costs and public skepticism, Democrats are increasingly confident that they"ll enact a vast health care overhaul. McClatchy reports: "The White House is ramping up its behind-the-scenes lobbying of Congress. President Barack Obama is signaling that he could drop some key principles of his campaign if necessary to jump-start negotiations, opening the door to broad tax increases and a plan that could, he now concedes, push people into a government-run insurance program against their will. Senate Democrats also said last week that they were heading toward agreement again after a momentary stall. ... Republicans, too, concede that the Democrats who control Congress and the White House are back on track to push an overhaul into law."
Sexual Health

805 Confirmed Cases Of H1N1 Swine Flu (H1N1) Virus In Canada

The PHAC (Public Health Agency of Canada) announced that as at the end of 22 May, 2009, the total number of confirmed swine flu cases is 805, including one death, in 9 provinces and 1 territory. Half of all confirmed human infections are under 22 years of age. 21 people have been hospitalized. Below is geographical breakdown of all laboratory confirmed cases: *British Columbia - confirmed cases 115 *Alberta - confirmed cases 94, 1 death *Saskatchewan - confirmed cases 77 *Manitoba - confirmed cases 6 *Ontario - confirmed cases 294 *Quebec - confirmed cases 143 *New Brunswick - confirmed cases 2 *Nova Scotia - confirmed cases 70 *Prince Edward Island - confirmed cases 3 *Newfoundland - confirmed cases 0 *Yukon - confirmed cases 1 *Northwest Territories - confirmed cases 0 *Nunavut - confirmed cases 0 Total - confirmed cases 805, 1 death The number of reports of onset of symptoms peaked on 8th May, and has steadily dropped since that date, Health Canada reports. However, the government of Canada says it expects to see more cases of H1N1 infection. Fortunately, the majority of cases continue to be mild, says Health Canada. Experts believe the next human flu season will be more intense than usual, partly because of the presence of this novel H1N1 virus strain (swine flu virus). However, so far this novel flu virus is nowhere near as virulent as was initially feared. Written by Christian Nordqvist. Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009